ENDRA Life Sciences Inc.·4

Jan 4, 5:03 PM ET

Basenese Lou 4

4 · ENDRA Life Sciences Inc. · Filed Jan 4, 2022

Insider Transaction Report

Form 4
Period: 2022-01-03
Basenese Lou
Director
Transactions
  • Award

    Stock Options

    2022-01-03+12,00012,000 total
    Exercise: $0.74From: 2023-01-03Exp: 2032-01-03Common Stock (12,000 underlying)
Footnotes (1)
  • [F1]Represents a stock option award granted on January 3, 2022 pursuant to the Issuer's Non-Employee Director Compensation Policy.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION